News

Press Releases

Asuragen to Present at 2017 American Society of Human Genetics (ASHG) Conference
Asuragen CEO to Speak at 2017 World CDx Summit
Asuragen Expands QuantideX® qPCR BCR-ABL Portfolio for Monitoring Molecular Response in Chronic Myeloid Leukemia
Asuragen Strengthens Repetitive Sequence and Short Structural Variant Intellectual Property Portfolio
Asuragen Launches the AmplideX® PCR/CE TOMM40 Kit1 Expanding Portfolio into the Alzheimer’s and Cognitive Impairment Space
Asuragen and Thermo Fisher Scientific to Collaborate on Diagnostic Kits for 3500 Dx Series Genetic Analyzer
Asuragen to Present at 2016 Association for Molecular Pathology Annual Meeting
Asuragen Launches QuantideX® NGS RNA Lung Cancer Kit (RUO)
Asuragen Develops Armored RNA Quant® Zika Virus Control
Asuragen’s QuantideX® qPCR BCR-ABL IS Kit Receives FDA Premarket Clearance for Monitoring Minimal Residual Disease in Chronic Myeloid Leukemia

About

Back To
Top